These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18772576)

  • 61. [Toxic epidermal necrolysis after treatment with lamotrigine].
    Zachariae CO; Fogh K
    Ugeskr Laeger; 1998 Nov; 160(46):6656-7. PubMed ID: 9825684
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica.
    East-Innis AD; Thompson DS
    West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis: frozen-section diagnosis.
    Hosaka H; Ohtoshi S; Nakada T; Iijima M
    J Dermatol; 2010 May; 37(5):407-12. PubMed ID: 20536645
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand.
    Abe R; Shimizu T; Shibaki A; Nakamura H; Watanabe H; Shimizu H
    Am J Pathol; 2003 May; 162(5):1515-20. PubMed ID: 12707034
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
    Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Nine years of a single referral center management of Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome).
    Monteiro D; Egipto P; Barbosa J; Horta R; Amarante J; Silva P; Silva A
    Cutan Ocul Toxicol; 2017 Jun; 36(2):163-168. PubMed ID: 27487073
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Leflunomide-induced toxic epidermal necrolysis in a patient with rheumatoid arthritis.
    Hassikou H; El Haouri M; Tabache F; Baaj M; Safi S; Hadri L
    Joint Bone Spine; 2008 Oct; 75(5):597-9. PubMed ID: 18805724
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Severe pneumonia caused by combined infection with Pneumocystis jiroveci, parainfluenza virus type 3, cytomegalovirus, and Aspergillus fumigatus in a patient with Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Lee T; Bae YJ; Park SK; Park HJ; Kim SH; Cho YS; Moon HB; Lee SO; Kim TB
    Acta Derm Venereol; 2010 Nov; 90(6):625-9. PubMed ID: 21057748
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme.
    Bastuji-Garin S; Rzany B; Stern RS; Shear NH; Naldi L; Roujeau JC
    Arch Dermatol; 1993 Jan; 129(1):92-6. PubMed ID: 8420497
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum.
    Power WJ; Ghoraishi M; Merayo-Lloves J; Neves RA; Foster CS
    Ophthalmology; 1995 Nov; 102(11):1669-76. PubMed ID: 9098260
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective descriptive study.
    Carrasquillo OY; Santiago-Vazquez M; Cardona R; Cruz-Manzano M; Figueroa LD
    Int J Dermatol; 2019 Nov; 58(11):1293-1299. PubMed ID: 31166019
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Procalcitonin as a diagnostic indicator for systemic bacterial infections in patients with Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Wang Q; Tian XB; Liu W; Zhang LX
    J Dermatol; 2018 Aug; 45(8):989-993. PubMed ID: 29897140
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Stevens-Johnson syndrome and toxic epidermal necrolysis; therapy policy in these life-threatening illnesses. Netherlands Work Group Toxic Epidermal Necrolysis].
    van der Meer JB
    Ned Tijdschr Geneeskd; 1996 Jul; 140(30):1538-43. PubMed ID: 8765761
    [No Abstract]   [Full Text] [Related]  

  • 74. Adverse drug reactions and organ damage: The skin.
    Marzano AV; Borghi A; Cugno M
    Eur J Intern Med; 2016 Mar; 28():17-24. PubMed ID: 26674736
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Stevens-Johnson syndrome and toxic epidermal necrolysis: retrospective study of 185 cases in Abidjan (Côte d'Ivoire)].
    Kourouma S; Sangaré A; Kaloga M; Kouassi I; Ecra E; Gbery I; Ahogo C; Kouassi A; Kassi K; Camara B
    Med Sante Trop; 2014; 24(1):94-8. PubMed ID: 24736218
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evaluation of the patients diagnosed with Stevens Johnson syndrome and toxic epidermal necrolysis: a single center experience.
    Çekiç Ş; Canıtez Y; Sapan N
    Turk Pediatri Ars; 2016 Sep; 51(3):152-158. PubMed ID: 27738400
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Oxcarbazepine induced toxic epidermal necrolysis - a rare case report.
    Guleria VS; Sharda C; Rana T; Sood AK
    Indian J Pharmacol; 2015; 47(4):459-61. PubMed ID: 26288485
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Results of Detailed Investigations Into Stevens-Johnson Syndrome With Severe Ocular Complications.
    Ueta M
    Invest Ophthalmol Vis Sci; 2018 Nov; 59(14):DES183-DES191. PubMed ID: 30481825
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Stevens-Johnson Syndrome and cholestatic hepatitis.
    Morelli MS; O'Brien FX
    Dig Dis Sci; 2001 Nov; 46(11):2385-8. PubMed ID: 11713940
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Stevens-Johnson syndrome due to lymecycline].
    Lehembre S; Modeste AB; Joly P
    Ann Dermatol Venereol; 2007 May; 134(5 Pt 1):461-3. PubMed ID: 17507845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.